Goodwin
Julie Tibbets
- Deals
- 5
- Latest
- Aug 2026
- Most deals in
- Biotech
Firm
- Goodwin Law firm · 2026 · 5 deals
Often works with
- Malhar Naik 4 deals together
- Dan Karelitz 3 deals together
- Gozde Guckaya 3 deals together
- Timothy Holahan 2 deals together
- Daniel Karelitz 2 deals together
- Matthew Wetzel 2 deals together
- Kingsley L. Taft 2 deals together
- Heath Ingram 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Aug 2026 | Amylyx Pharmaceuticals | – | – | Follow-on offering | Legal adviser to the issuer | Announced | 575.2 | Biotech+1 | Amylyx Pharmaceuticals equity raising |
| Apr 2026 | CathWorks | – | Medtronic | Acquisition | Legal adviser to CathWorks (target) | Announced | 585.0 | Medtech+1 | Medtronic acquisition of CathWorks |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Ouro Medicines (target) | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Mar 2026 | Pikavation | Synnovation | Novartis | Acquisition | Legal adviser to Synnovation Therapeutics (seller) | Announced | 2,000.0 | Biotech+2 | Novartis acquisition of Pikavation |
| Feb 2026 | Laysan Bio | – | Gannet BioChem | Acquisition | Legal adviser to Gannet BioChem (acquirer) | Announced | – | Pharma Services+2 | Gannet BioChem acquisition of Laysan Bio |
Deals where Julie Tibbets is named on the firm's deal team, by the firm or the press.